233Vigneswaran N, Wu J, Song A, Annapragada A, Zacharias W (2011) Hypoxia-induced autoph-
agic response is associated with aggressive phenotype and elevated incidence of metastasis
in orthotopic immunocompetent murine models of head and neck squamous cell carcinomas
(HNSCC). Exp Mol Pathol 90:215–225
Visvader JE, Lindeman GJ (2008) Cancer stem cells in solid tumours: accumulating evidence and
unresolved questions. Nat Rev Cancer 8:755–768
Wang M, Li X, Lu X, Qu Y, Xu O, Sun Q (2011) Cancer stem cells promotes resistance of laryn-
geal squamous cancer to irradiation mediated by hypoxia. Lin chuang er bi yan hou tou jing
wai ke za zhi. J Clin Otorhinolaryngol Head Neck Surg 25:823–826
Wang SJ, Earle C, Wong G, Bourguignon LY (2013) Role of hyaluronan synthase 2 to promote
CD44-dependent oral cavity squamous cell carcinoma progression. Head Neck 35:511–520
Wang TY, Peng CY, Lee SS, Chou MY, Yu CC, Chang YC (2016) Acquisition cancer stemness,
mesenchymal transdifferentiation, and chemoresistance properties by chronic exposure of oral
epithelial cells to arecoline. Oncotarget 7:84072–84081
Westermarck J, Li S, Jaakkola P, Kallunki T, Grénman R, Kähäri VM (2000) Activation of fibro-
blast collagenase-1 expression by tumor cells of squamous cell carcinomas is mediated by p38
mitogen-activated protein kinase and c-Jun NH2-terminal kinase-2. Cancer Res 60:7156–7162
Whiteside TL (2006a) The role of immune cells in the tumor microenvironment. In: The link
between inflammation and cancer. Springer, Boston, pp 103–124
Whiteside TL (2006b) Immune suppression in cancer: effects on immune cells, mechanisms and
future therapeutic intervention. Semin Cancer Biol 16:3–15
Winquist RJ, Boucher DM, Wood M, Furey BF (2009) Targeting cancer stem cells for more effec-
tive therapies: Taking out cancer’s locomotive engine. Biochem Pharmacol 78:326–334
Wu CP, Du HD, Gong HL, Li DW, Tao L, Tian J et al (2014) Hypoxia promotes stem-like prop-
erties of laryngeal cancer cell lines by increasing the CD133+ stem cell fraction. Int J Oncol
44:1652–1660
Xie T, Li L (2007) Stem cells and their niche: an inseparable relationship. Development
134:2001–2006
Yang CC, Zhu LF, Xu XH, Ning TY, Ye JH, Liu LK (2013) Membrane Type 1 Matrix
Metalloproteinase induces an epithelial to mesenchymal transition and cancer stem cell-like
properties in SCC9 cells. BMC Cancer 13:171
Ye X, Zhang J, Lu R, Zhou G (2016) Signal regulatory protein alpha associated with the progres-
sion of oral leukoplakia and oral squamous cell carcinoma regulates phenotype switch of mac-
rophages. Oncotarget 7:81305–81321
Young MRI (2006) Protective mechanisms of head and neck squamous cell carcinomas from
immune assault. Head Neck 28:462–470
Yun CO (2008) Overcoming the extracellular matrix barrier to improve intratumoral spread and
therapeutic potential of oncolytic virotherapy. Curr Opin Mol Ther 10:356–361
Zamarron BF, Chen W (2011) Dual roles of immune cells and their factors in cancer development
and progression. Int J Biol Sci 7:651–658
Zeng Q, Li S, Chepeha DB, Giordano TJ, Li J, Zhang H et al (2005) Crosstalk between tumor and
endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. Cancer
Cell 8:13–23
Zhang Z, Sant’Ana Filho M, Nör JE (2012) The biology of head and neck cancer stem cells. Oral
Oncol 48:1–9
Zhang H, Wu H, Zheng J, Yu P, Xu L, Jiang P et al (2013) Transforming growth factor β1 signal
is crucial for dedifferentiation of cancer cells to cancer stem cells in osteosarcoma. Stem Cells
31:433–446
Zhou BB, Zhang H, Damelin M, Geles KG, Grindley JC, Dirks PB (2009) Tumour-initiating cells:
challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov 8:806–823
Ziober AF, Falls EM, Ziober BL (2006) The extracellular matrix in oral squamous cell carcinoma:
friend or foe? Head Neck 28:740–749
11 Oral Cancer Stem Cells Microenvironment